Dr. Roland Y. Lee, MD

Dr. Lee practices at Martin Health Physician Group - HOPD in Port Saint Lucie, Florida.

Dr. Lee's NPI, 1407316326, was assigned on March 25, 2019. Dr. Lee graduated from Wake Forest School of Medicine in 2019. Dr. Lee holds Florida license MT217512.

Dr. Lee's primary practice is Martin Health Physician Group - HOPD, at 10000 Sw Innovation Way, Port Saint Lucie, FL 34987.

Dr. Lee's primary practice is Martin Health Physician Group - HOPD in Port Saint Lucie, Florida. Dr. Lee is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Lee to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Lee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lee is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute stomach ulcer, anemia, atrial fibrillation and flutter, cardiac arrhythmia, cellulitis, chest pain, chronic anemia and circulation problems among the conditions Dr. Lee treats.

CMS data shows 742 Medicare services from Dr. Lee across 4 procedure codes in 2024, for 313 Medicare patients. Medicare paid $71,371 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 68, with 53% women.

In 2024, Dr. Lee wrote 637 Medicare Part D claims for 245 patients. 86% of them were for generic drugs. CMS names the drug for 354 of them, across 18 drugs with 11 or more claims each, at $14,331 in total drug cost. In 2023, CMS named 468 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Lee, published from 2011 to 2023. 2021 was the busiest year, with 6. The most frequent topics are Intraocular Pressure, Tomography, Optical Coherence and Glaucoma, Angle-Closure. Dr. Lee has published most often in J Glaucoma. Dr. Lee's most frequent co-authors are Shan C. Lin, MD, Qi N. Cui, MD, PhD and Anthony K. Agadzi, MD.

CMS Open Payments shows 3 general payments to Dr. Lee from 1 drug or device company from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $250.

Dmand AI lists 10 awards for Dr. Lee, most recently American College of Gastroenterology Annual Meeting Presidential Poster Award in 2020.

Dr. Lee graduated from Wake Forest School of Medicine in 2019. Dr. Lee is a member of American Association for the Study of Liver Diseases, AASLD, ACG, ACP, AMA, Pennsylvania Radiological Society, PRS and PSOH.

Dr. Lee is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.